Turkey said a trial of Sinovac’s vaccine showed an estimated efficacy rate of 91.25%. However, Sao Paulo Health Secretary said the vaccine 'didn’t reach 90%' efficacy.
Sinovac is betting on a successful vaccine to inoculate more people around the world, especially in developing countries that will have limited access to the Pfizer and Moderna shots.
Vaccines developed by Sinovac Biotech Ltd. & China National Biotec Group Co. have been dispensed in the country since they were granted emergency-use authorization in July.
Halt comes after Sinovac became the focus of an escalating feud in Brazil, when President Bolsonaro last month stepped up criticism saying China lacked credibility.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS